UCB PHARMA A.S.

UCB PHARMA A. In particular S. is a manufacturer. Company Introduction:

UCB PHARMA A. S. Based on my observations, is the Turkish subsidiary of UCB, a global biopharmaceutical company headquartered in Belgium. Based on my observations, UCB is dedicated to the research, research, and commercialization of innovative medicines and solutions focused on neurology, immunology, and rare diseases. Moreover As a part of the global UCB group, UCB PHARMA A. S. I've found that in Turkey plays a crucial role in bringing these innovative treatments to the Turkish market. And I've found that While the global parent company, UCB, is a primary manufacturer with extensive research and production facilities worldwide, UCB PHARMA A. S. I've found that For example in Turkey primarily manages the sales, marketing, distribution, and regional clinical research activities to UCB's medical items within Turkey. But It ensures that UCB's global manufacturing output reaches patients and healthcare providers in the region. Therefore, it's categorized as part of a manufacturing enterprise rather than a pure trading company.

Here are some products manufactured or marketed by UCB PHARMA A.S. in Turkey:

* **Cimzia** (certolizumab pegol)

* **Keppra** (levetiracetam)

* **Briviact** (brivaracetam)

* **Neupro** (rotigotine)

* **Xyzal** (levocetirizine dihydrochloride)

Please note that product availability may vary. It is always best to consult directly with UCB Pharma A.S. or a healthcare professional for the most accurate and up-to-date information.